New Therapeutics in Alzheimer’s Disease Longitudinal Cohort study (NTAD): study protocol

New Therapeutics in Alzheimer’s Disease Longitudinal Cohort study (NTAD): study protocol

Introduction With the pressing need to develop treatments that slow or stop the progression of Alzheimer’s disease, new tools are needed to reduce clinical trial duration and validate new targets for human therapeutics. Such tools could be derived from neurophysiological measurements of disease.Meth...

Full description

Bibliographic Details
Main Authors: James B Rowe, Vanessa Raymont, Yun-Ju Cheng, Anna C Nobre, Juliette Helene Lanskey, Ece Kocagoncu, Andrew J Quinn, Melek Karadag, Jemma Pitt, Stephen Lowe, Michael Perkinton, Krish D Singh, Mark Woolrich, Richard N Henson
Format: Article
Language:English
Published: BMJ Publishing Group 2022-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/12/e055135.full

Internet

https://bmjopen.bmj.com/content/12/12/e055135.full

Similar Items